Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP475 | DOI: 10.1530/endoabs.110.EP475

ECEESPE2025 ePoster Presentations Diabetes and Insulin (245 abstracts)

Time in tight range (TITR) stratified by coefficient of variation (CV) in a cohort of patients with type 1 diabetes mellitus and multiple daily injections. a real-life study

Sandra Herranz-Antolín 1 , Sofía Ramos-Garrido 1 , Verónica Esteban-Monge 1 , Clara Cotón-Batres 1 , María Covadonga López-Virgos 1 , Marta Cano Megias 1 & Miguel Torralba 1


1Hospital Universitario de Guadalajara, Guadalajara, Spain


JOINT1205

Objetive: To analyze the TITR (70-140 mg/dL) and assess their possible differences according to CV in a cohort of type 1 DM patient with MDI.

Patients and Methods: 355 adult users of isCGM with at least a HbA1c during the period October 1, 2023-October 1, 2024, and glucose data in the 90 days prior (or at least 60 days) were included.

Results: Age 46.9 years (SD 13.6); 57.2% male; age at diagnosis 25.6 years (SD 14.3); time of evolution 21.6 years (SD 12.6); HbA1c 7.2% (SD 1.1). Glucometric parameters: glucose 165.9 mg/dL (SD 31.5), TITR 38.4% (20.3% had a TITR ≥ 50%), TIR (70-180 mg/dL) 60.4% (SD 16.5), TBR1 (54-69 mg/dL) 3.3% (SD 2.8), TBR2 (< 54 mg/dL) 0.5% (SD 0.8), TAR1 (181-250 mg/dL) 23.3% (SD 8.4), TAR2 (> 250 mg/dL) 12.4% (SD 12.1), CV 37.1% (SD 6.2), GMI 7.3% (SD 0.8) and GRI 47.8% (SD 21).

Table 1: Clinical characteristics and glucometric parameters according to the CV.
CV ≤ 36% (n = 156)CV > 36% (n = 199)P
Age (years)48.3 (SD 13.6)45.9 (SD 13.5)0.094
Gender (male) (%)59.456.10.534
Age at diagnosis (years)27.5 (SD 14.7)24.1 (SD 13.8)0.029
Time of evolution (years)21.1 (SD 13.5)21.9 (SD 11.9)0.482
Mean glucose (mg/dL)151.4 (SD 35.1)169.4 (SD 27.4)0.022
TITR (%)40.8 (SD 16.4)36.4 (SD 10.4)0.008
TITR ≥ 50% (%)31.411.6< 0.001
TIR (%)65.5 (SD 19.8)56.5 (SD 12.1)< 0.001
TBR1 (%) TBR2 (%)1.9 (SD 2.4) 0.2 (SD 0.4)4.4 (SD 2.6) 0.8 (SD 0.9)< 0.001 < 0.001
TAR1 (%) TAR2 (%)23.1 (SD 11.1) 9.3 (SD 13.3)23.5 (SD 5.7) 14.8 (SD 10.4)0.667 < 0.001
CV (%)31.5 (SD 3.3)41.5 (SD 4.1)< 0.001
GMI (%)7.2 (SD 0.8)7.4 (SD 0.7)0.022
GRI (%)38.1 (SD 22.8)55.5 (SD 15.8)< 0.001
HbA1c (%)7.1 (SD 1.2)7.3 (SD 0.9)0.049
The correlation TITR-TIR was high and differs depending on CV (patients with CV ≤ 36%: β = 0.88; CI 95% 0.83-0.93; R2 Adjusted 0.89; P< 0.001 – patients with CV > 36%: β = 0.84; CI 95% 0.81-0.87; R2 Adjusted 0.94; P< 0.001)

Conclusions: The percentage of patients achieving TITR ≥ 50% is higher in patients with lower glycemic variability. The correlation TITR-TIR is high and modified by glycemic variability.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches